Vascular and Metabolic Consequences of Adopting a Westernized Lifestyle
1 other identifier
interventional
52
1 country
1
Brief Summary
The purpose of this study is to determine if short-term adoption of a Westernized lifestyle characterized by physical inactivity and increased consumption of fructose will result in metabolic and vascular dysfunction. Healthy individuals aged 18-45 years old will undergo an acute period of physical inactivity (10 days) coupled with increased fructose consumption. Augmented fructose consumption will be achieved via commercially available soda beverages which are high in fructose. Vascular and metabolic function measures will be performed before and after the 10-day intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2018
CompletedFirst Submitted
Initial submission to the registry
December 17, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2022
CompletedAugust 17, 2022
August 1, 2022
3.7 years
December 17, 2018
August 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insulin-stimulated leg blood flow
Subjects will be instrumented with EKG for contrast-enhanced ultrasound (CEU) measurements. We will perform a hyperinsulinemic euglycemic clamp to evaluate microvascular perfusion of skeletal muscle via CEU. Insulin will be infused at a constant rate to mimic postprandial insulin concentrations and glucose maintained at fasting values via a variable 20% dextrose infusion. At baseline and in the steady state phase of the insulin clamp, we will assess microvascular perfusion in the vastus lateralis muscle using CEU (IE-33, Philips Ultrasound), via infusion of perflutren lipid microspheres. Microvascular perfusion will be assessed as an A-value. A is the video intensity plateau after complete replenishment reflecting relative microvascular blood volume (MBV).
this will be assessed at baseline and at the final visit (10 days)
Secondary Outcomes (2)
Change in Brachial artery flow mediated dilation (FMD)
this will be assessed at baseline and at the final visit (10 days)
Change in carotid femoral pulse wave velocity (cfPWV)
this will be assessed at baseline and at the final visit (10 days)
Study Arms (1)
Fructose and physical inactivity
EXPERIMENTALSubjects will consume 6 cans of soda per day and restrict their physical activity.
Interventions
Subjects will drink 6 cans of regular sodas daily (divided throughout the day) and will decreased physical activity to less than 5000 steps daily for 10 days.
Eligibility Criteria
You may qualify if:
- Men and women who regularly engage in \>10,000 steps per day
- Age 18-45 years
- Body mass index \< 30 kg/m2
- No history of chronic disease
You may not qualify if:
- Known cardiovascular disease including hypertension, heart failure, coronary artery disease, and stroke
- Renal or hepatic diseases
- Active cancer
- Autoimmune diseases
- Current use of immunosuppressant therapy
- Excessive alcohol consumption (\> 14 drinks/week for men and \>7 drinks/week for women)
- Current tobacco use
- Current pregnancy
- Diagnosis of type 2 diabetes
- Regular consumption of \>2 non-diet sodas/day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri
Columbia, Missouri, 65212, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Camila Manrique Acevedo, MD
University of Missouri-Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Endocrinology
Study Record Dates
First Submitted
December 17, 2018
First Posted
December 24, 2018
Study Start
November 30, 2018
Primary Completion
August 1, 2022
Study Completion
August 16, 2022
Last Updated
August 17, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share